FHYNE DULNUAN: Open Payments
NPI 1144723339 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 66 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $509 · 2025 $1,361
Food & beverage: $1,310Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $377 |
| Janssen Biotech, Inc. | 13 | $254 |
| Phathom Pharmaceuticals, Inc. | 11 | $241 |
| PFIZER INC. | 7 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| Ardelyx, Inc. | 3 | $70 |
| Madrigal Pharmaceuticals | 2 | $57 |
| EVOKE PHARMA, INC. | 1 | $15 |
Products named: TREMFYA, VOQUEZNA, CREON, VELSIPITY, LINZESS, ENTYVIO, IBSRELA, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
